349 related articles for article (PubMed ID: 8586032)
1. Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukaemia.
Gillis JC; Goa KL
Drugs; 1995 Nov; 50(5):897-923. PubMed ID: 8586032
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid in acute promyelocytic leukaemia.
Avvisati G; Tallman MS
Best Pract Res Clin Haematol; 2003 Sep; 16(3):419-32. PubMed ID: 12935960
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.
Cheng Y; Zhang L; Wu J; Lu A; Wang B; Liu G
Eur J Haematol; 2013 Dec; 91(6):483-9. PubMed ID: 24033687
[TBL] [Abstract][Full Text] [Related]
4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
5. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).
Warrell RP; Frankel SR; Miller WH; Scheinberg DA; Itri LM; Hittelman WN; Vyas R; Andreeff M; Tafuri A; Jakubowski A
N Engl J Med; 1991 May; 324(20):1385-93. PubMed ID: 1850498
[TBL] [Abstract][Full Text] [Related]
6. Differentiation and apoptosis induction therapy in acute promyelocytic leukaemia.
Wang ZY; Chen Z
Lancet Oncol; 2000 Oct; 1():101-6. PubMed ID: 11905660
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
Robak T
Acta Haematol Pol; 1995; 26(3):269-77. PubMed ID: 8525772
[TBL] [Abstract][Full Text] [Related]
8. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond.
Tallman MS
Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894
[TBL] [Abstract][Full Text] [Related]
9. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
Zhou GB; Zhang J; Wang ZY; Chen SJ; Chen Z
Philos Trans R Soc Lond B Biol Sci; 2007 Jun; 362(1482):959-71. PubMed ID: 17317642
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acids in the treatment of acute promyelocytic leukemia.
Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
[TBL] [Abstract][Full Text] [Related]
11. All-trans-retinoic acid in acute promyelocytic leukemia.
Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of all-trans retinoic acid in adults and children with acute promyelocytic leukemia.
Takitani K; Koh M; Inoue A; Kawakami C; Kuno T; Tamai H
Am J Hematol; 2006 Sep; 81(9):720-1. PubMed ID: 16838336
[No Abstract] [Full Text] [Related]
13. Arsenic trioxide: new preparation. Acute promyelocytic leukaemia: encouraging results but persistent doubts.
Prescrire Int; 2004 Aug; 13(72):135-7. PubMed ID: 15532137
[TBL] [Abstract][Full Text] [Related]
14. [Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
Lengfelder E; Simon M; Haase D; Hild F; Hehlmann R
Dtsch Med Wochenschr; 1994 Aug; 119(34-35):1143-50. PubMed ID: 8076501
[TBL] [Abstract][Full Text] [Related]
15. Molecular remission induction with retinoic acid and anti-CD33 monoclonal antibody HuM195 in acute promyelocytic leukemia.
Jurcic JG; DeBlasio T; Dumont L; Yao TJ; Scheinberg DA
Clin Cancer Res; 2000 Feb; 6(2):372-80. PubMed ID: 10690513
[TBL] [Abstract][Full Text] [Related]
16. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia.
Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C
Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute promyelocytic leukaemia relapsing after allogeneic bone marrow transplantation with all-trans-retinoic acid: suppression of the leukaemic clone.
Bashford J; Szer J; Wiley JS; Buckley M; Garson OM; Van der Weyden MB
Br J Haematol; 1991 Oct; 79(2):331-4. PubMed ID: 1958492
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
Lou Y; Qian W; Meng H; Mai W; Tong H; Tong Y; Huang J; Jin J
Hematol Oncol; 2014 Mar; 32(1):40-6. PubMed ID: 23963734
[TBL] [Abstract][Full Text] [Related]
19. Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.
Burnett AK; Russell NH; Hills RK; Bowen D; Kell J; Knapper S; Morgan YG; Lok J; Grech A; Jones G; Khwaja A; Friis L; McMullin MF; Hunter A; Clark RE; Grimwade D;
Lancet Oncol; 2015 Oct; 16(13):1295-305. PubMed ID: 26384238
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
